Additional file 1 of Surgery for stage IIB–IIIB small cell lung cancer
Creators: name: Huang, Zhida
name: Liu, Yue
name: Wang, Suyu
name: Ai, Kaixing
name: Zhang, Peng
Publisher: name: figshare
Year: 2023
Subjects: subject: Space Science
subject: Medicine
subject: Cell Biology
subject: Genetics
subject: FOS: Biological sciences
subject: Ecology
subject: Biological Sciences not elsewhere classified
subject: Marine Biology
subject: Cancer
subject: Science Policy

description: Additional file 1: Supplementary Table 1. Univariable/multivariable Cox regression analysis of the influence of surgery (surgery vs. no surgery) on OS of stage T3-4N0M0/T1-4N1-2M0 SCLC. Supplementary Table 2. Univariable/multivariable Cox regression analysis of the influence of surgery (sublobectomy/lobectomy/pneumonectomy vs. no surgery) on OS of stage T3-4N0M0/T1-4N1-2M0 SCLC. Supplementary Fig. 1. SMD between surgery and no surgery (A), sublobectomy and no surgery (B), lobectomy and no surgery (C), pneumonectomy and no surgery (D) before and after PSM, lobectomy plus chemoradiotherapy and chemoradiotherapy (E) before and after PSM. The dotted lines denote the SMD of -0.1 and 0.1. SMD, standardized mean difference; PSM, propensity score matching. Supplementary Fig. 2. SMD between surgery and no surgery in patients with stage IIB (A), stage IIIA (B), and stage IIIB (C) before and after PSM. The dotted lines denote the SMD of -0.1 and 0.1. SMD, standardized mean difference; PSM, propensity score matching. Supplementary Fig. 3. SMD between surgery vs. no surgery (A), sublobectomy vs. no surgery (B), lobectomy vs. no surgery (C), and pneumonectomy vs. no surgery (D) in patients with stage T3-4N0M0/T1-4N1-2M0 SCLC before and after PSM adjusting tumor size, T classification, N classification and other baseline characteristics. The dotted lines denote the SMD of -0.1 and 0.1. SMD, standardized mean difference; PSM, propensity score matching. Supplementary Fig. 4. Kaplan-Meier curves of OS for stage T3-4N0M0/T1-4N1-2M0 SCLC comparing surgery vs. no surgery (A), sublobectomy vs. no surgery (B), lobectomy vs. no surgery (C), and pneumonectomy vs. no surgery (D) after PSM adjusting tumor size, T classification, N classification and other baseline characteristics. OS, overall survival; SCLC, small cell lung cancer, PSM, propensity score matching. Supplementary Fig. 5. SMD between sublobectomy vs. no surgery (A), lobectomy vs. no surgery (B), and pneumonectomy vs. no surgery (C) in patients with stage IIIA SCLC before and after PSM. The dotted lines denote the SMD of -0.1 and 0.1. SMD, standardized mean difference; PSM, propensity score matching. Supplementary Fig. 6. Kaplan-Meier curves of OS for stage IIIA SCLC comparing sublobectomy vs. no surgery (A, B), lobectomy vs. no surgery (C, D), and pneumonectomy vs. no surgery (E, F) before and after PSM. OS, overall survival; SCLC, small cell lung cancer, PSM, propensity score matching. Supplementary Fig. 7. SMD between sublobectomy vs. no surgery (A) and lobectomy vs. no surgery (B) in patients with stage IIIB SCLC before and after PSM. The dotted lines denote the SMD of -0.1 and 0.1. SMD, standardized mean difference; PSM, propensity score matching. Supplementary Fig. 8. Kaplan-Meier curves of OS for stage IIIB SCLC comparing sublobectomy vs. no surgery (A, B) and lobectomy vs. no surgery (C, D) before and after PSM. OS, overall survival; SCLC, small cell lung cancer, PSM, propensity score matching.